A phase 2 liver trial where the add-on drug didn't help — and the base drug quietly did
Read the Sunday Brief →

Study wrapper · #927

Do GLP-1 Receptor Agonists Sabotage Fat Grafts? A Scoping Review of GLP-1 Receptor Agonist Effects on Adipocyte Biology and Implications for Autologous Fat Transfer.

Chalhoub X, Yang Ng Z Aesthetic surgery journal. 2026.

Editor's note

This scoping review maps mechanistic reasons GLP-1-class drugs might interfere with autologous fat grafting, but the authors stress no clinical or preclinical studies have directly examined this outcome. The conclusions are explicitly hypothesis-generating rather than evidence-based. Retatrutide is mentioned partly in the context of off-label bodybuilding use.

Plain-language abstract

A scoping review exploring how GLP-1 receptor agonists including semaglutide, tirzepatide, and retatrutide may affect fat cell biology and the survival of transferred fat grafts, noting no direct studies exist yet.